THE GAP REPORT 2014 PRisOnERs

Similar documents
HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

FAST-TRACK COMMITMENTS TO END AIDS BY 2030

Understanding Key Populations: Removing Legal Barriers to Prisons Health and Human Rights. Nthabiseng Mokoena

HIV AND PEOPLE WHO INJECT DRUGS

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

GLOBAL STATISTICS FACT SHEET 2015

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

Six things you need to know

Tuberculosis-related deaths in people living with HIV have fallen by 36% since 2004.

who inject drugs THE GAP REPORT 2014

Technical Guidance Note for Global Fund HIV Proposals

Harm Reduction in Nigeria

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1

United Nations Office on Drugs and Crime (UNODC)

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

UPDATE UNAIDS 2016 DATE 2016

THE BENCHMARK. UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response.

Towards universal access

BUDGET AND RESOURCE ALLOCATION MATRIX

Gender inequality and genderbased

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

Government of Canada Federal AIDS Initiative Milestones

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

DUBLIN DECLARATION ON HIV/AIDS IN PRISONS IN EUROPE AND CENTRAL ASIA

The road towards universal access

People left behind: Sex workers

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

Latest Funding Trends in AIDS Response

World Health Organization. A Sustainable Health Sector

THE GAP REPORT 2014 DisPlAcED PERsOns

Prisons and AIDS UNAIDS. point of view. April UNAIDS Best Practice Collection

World Food Programme (WFP)

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012

60TH SESSION OF THE UNITED NATIONS COMMISSION ON HUMAN RIGHTS

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA

COMMUNITY. Stigma and Discrimination Experienced by Sex Workers Living with HIV

UNAIDS 2013 AIDS by the numbers

Snapshot of the Global HIV Pandemic among Adolescents and Young People

As a result of this training, participants will be able to:

IFMSA Policy Statement Ending AIDS by 2030

Version for the Silent Procedure 29 April Agenda item January Hepatitis

WOMEN: MEETING THE CHALLENGES OF HIV/AIDS

UNAIDS 2014 REFERENCE BURUNDI DEVELOPING SUBNATIONAL ESTIMATES OF HIV PREVALENCE AND THE NUMBER OF PEOPLE LIVING WITH HIV

HIV and Harm Reduction in Prisons

As a result of this training, participants will be able to:

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

Children and AIDS Fourth Stocktaking Report 2009

Towards a global HIV prevention coalition and road map. Preventing and reducing new HIV infections by 75% by 2020

Program to control HIV/AIDS

26 th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland June 2010

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies

UNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP

Translating Science to end HIV in Latin America and the Caribbean

UNAIDS Technical Support Division of Labour. Summary & Rationale

Viral Hepatitis. WHO Regional Office for Europe July 2013

Number of people receiving ARV therapy in developing and transitional countries by region,

HIV, STIGMA AND PRISON

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

2. Treatment coverage: 3. Quality of care: 1. Access to diagnostic services:

Prison needle exchange: Review of the evidence

WHO/HIV_AIDS/BN/ Original: English Distr.: General

Groups of young people in Uganda that need to be targeted with HIV interventions

Linkages between Sexual and Reproductive Health and HIV

Report of the 16 th. Core Group meeting Almaty, Kazakhstan May 26-28, 2010

2014 UBRAF thematic report

Scaling up priority HIV/AIDS interventions in the health sector

GLOBAL AIDS MONITORING REPORT

May 26-28, 2010, Almaty, Kazakhstan November 2011

STI and HIV Prevention and Care among Sex Workers

Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

Human rights, stigma and discrimination

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

HIV/AIDS ALL YOU NEED TO KNOW! BELIEVE ONLY IN FACTS!

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

UNAIDS 2018 THE YOUTH BULGE AND HIV

Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

Ending the AIDS Epidemic in Adolescents

Ensuring access to measures for the prevention of motherto-child transmission of HIV in prisons

Draft global health sector strategy on HIV,

ADDRESSING LEGAL AND POLICY BARRIERS. To Effective HIV Prevention

Harm reduction among drug users in Spain

Models of good practice in drug treatment in Europe. Project group

Improving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative

General Assembly. United Nations A/63/152/Add.1

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

HIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy

Identifying Common Ground on Public Health for UNGASS 2016:

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

Key Populations: Making Them Matter in the Global HIV Response Inextricable Links: HIV and Human Rights

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

ViiV Healthcare s Position on Prevention in HIV

Transcription:

THE GAP REPORT 2014 Prisoners Every year, 30 million people spend time in prisons or closed settings (1) and 10 million are incarcerated at any given point in time (2). Virtually all will return to their communities, many within a few months to a year. Health in prisons and other closed settings is thus closely connected to the health of the wider society. Prisons are often overcrowded due to inappropriate, ineffective and excessive criminal laws. People who are already more likely to be exposed to HIV, including people who use drugs, sex workers, and gay men and other men who have sex with men, are overrepresented in prisons and other closed settings. Overcrowding increases vulnerability to infections such as HIV, tuberculosis and hepatitis. Prisoners are also at risk of violence and disruption in HIV prevention and treatment services, including access to harm reduction measures.

PRisOnERs I am a prisoner. I face these issues. There are no condoms and lubricants in prison I have to share a needle to inject drugs because they are banned There is no methadone so I started injecting drugs again I am very sick but I cannot see a doctor My HIV treatment has stopped since coming to prison There is lots of unprotected sex in prison but nobody cares I was gang raped when I first arrived in prison 20 of us are locked in the same cell for hours each day I sold sex to feed my children. No one looks after them while I am here I have been locked up for months without a trial I am worried about my safety I am forced to have sex to protect myself from violence I do not know my rights and I don t have a lawyer 2

WHY PRISONERS ARE BEING LEFT BEHIND Every year, 30 million people spend time in prisons or closed settings (1), and 10 million are incarcerated at any given point in time (2). Virtually all will return to their communities, many within a few months to a year. Health in prisons and other closed settings is thus closely connected to the health of the wider society. Prisons are often overcrowded due to inappropriate, ineffective and excessive criminal laws. People who are already more likely to be exposed to HIV, including people who use drugs, sex workers and gay men and other men who have sex with men, are overrepresented in prisons and other closed settings. Overcrowding increases vulnerability to infections such as HIV, tuberculosis and hepatitis. Prisoners are also at risk of violence and disruption in HIV prevention and treatment services, including access to harm reduction measures. HIV burden The prevalence of HIV, sexually transmitted infections, hepatitis B and C and tuberculosis in prison populations has been estimated to be between two and 10 times higher than in the general population (3). In some settings, the HIV burden among prisoners may be up to 50 times higher than in the general population (9). In Mauritania, in 2012 there was an estimated HIV prevalence of 24.8% among prisoners, 40% of whom inject drugs (10). The Top 4 Reasons 01 Unmet health-care needs 02 Overcrowding 03 Sexual violence, unsafe sexual practices and unsafe drug injection practices 04 Inappropriate, ineffective and excessive laws It has been estimated that between 56 and 90% of people who inject drugs will be incarcerated at some stage (11). Women in prison settings HIV infection rates are particularly high among women in detention (4). Women who inject drugs who have been sex workers or who have experienced sexual violence are at higher risk of HIV and are disproportionately represented among the female prison population. A significant number of women will already have sexually transmitted infections at the time they enter prison (5,6). A 2010 report from Indonesia found that HIV prevalence was over five times higher in female (6%) than in male respondents (1%) (7,8). 3

HIV prevalence is higher among prisoners than in the general adult population in many countries Ukraine Argentina South Africa United States 2.4 times 2.4 times 15 times 10 times Sources: 1. South African national HIV prevalence, incidence and behaviour survey, 2012. Cape Town: Human Sciences Research Council; 2008. 2. HIV in correctional settings. Atlanta: Centers for Disease Control and Prevention; 2012. 3. World report 2011: Events of 2010. New York: Human Rights Watch; 2011. 4. Balakireva OM, Sudakova AV, Salabai NV, Kryvoruk AI. Analysis of HIV/AIDS response in penitentiary system of Ukraine. Summary report on the comprehensive study. Kyiv: Ukrainian Institute for Social Research after Olexander Yaremenko and United Nations Office on Drugs and Crime; 2012. Unmet health-care needs The health of prisoners is often neglected due to the intense stigma that this population faces and low levels of investments in their care. Budgetary constraints, along with legal and policy barriers and low political will to invest in prisoners care means that prison health services are often minimal (12). Most of the time access to health care in prison settings is limited and not equivalent to the services that are available in the wider community. When men and women living with HIV who are receiving treatment are arrested and incarcerated, it damages treatment retention and adherence (11), which risks their health. Health care in prisons is often provided by the ministry responsible for prison administration rather than by public health authorities (13,14). Consequently, prison HIV and coinfection service provision is often disconnected from national public health programmes. 4

Only a third of reporting countries in Europe provide opioid substitution therapy to over 10% of their prison population >10% 3 10% <3% Source: Dublin Declaration questionnaire, ECDC 2012. In prisons, there may be little or no access to prevention commodities such as condoms and lubricants or needle and syringe programmes. Opioid substitution therapy may not be available. Critical HIV services, including voluntary HIV testing and counselling, antiretroviral therapy for treatment, prevention of mother-tochild transmission or post-exposure prophylaxis, are much harder to access than in the community. In addition, lack of confidentiality, mandatory HIV testing or treatment without informed consent, denial of treatment, and segregation of people living with HIV are commonplace practices (15). Despite a high frequency of dual infection of tuberculosis and HIV, prisoners have been shown to respond well to HIV treatment (16). Effective treatment not only decreases the risk of mortality and the likelihood of developing active tuberculosis, it reduces the risk of further transmission of HIV to others. Treatment programmes should, therefore, be available to eligible prisoners after arrival, along with follow-up support to ensure continuity of care, especially during interfacility transfers and release. However, treatment adherence has proved to be challenging, particularly where food is scarce (17). Active detection and treatment of tuberculosis is also critical. In prisons, the health and safety of prisoners needs to be improved through protective laws, policies and programmes that are adequately resourced, monitored and enforced. Access to preventive, curative, reproductive and palliative health care should be equivalent to that provided in the community, in accordance with the United Nations Basic Principles for the Treatment of Prisoners, which recognizes that Prisoners shall have access to the health services available in the country without discrimination (18). When men and women living with HIV who are on treatment are arrested and incarcerated, it damages treatment retention and adherence. 5

Overcrowding On a global scale, the prison population is growing rapidly, leading to overcrowding in prisons and other closed settings like pretrial detention centres. In 16 countries, primarily in Africa, the occupancy rate was reported to exceed 200% (19). Overcrowding and ventilation, are the two main environmental conditions in which tuberculosis infection thrives (19). This has a particularly serious impact on people living with HIV, as they have around a 12 20 times greater risk of developing tuberculosis than people who do not have HIV (19); also, their weakened immune systems are harder hit by the infection. People living with HIV have around a 12 20 times greater risk of developing tuberculosis than people who do not have HIV. Overcrowding is found in prison settings in countries all around the world 350 300 Prison capacity (%) 250 200 150 100 50 0 Full capacity Haiti Philippines (the) Venezuela (Bolivarian Republic of) Kenya Prison population Iran (Islamic Republic of) Pakistan Brazil Italy South Africa Mexico France India United Kingdom (the) Source: International Centre for Prison Studies World Prison Briefs http://www.prisonstudies.org/world-prison-brief. Overcrowding increases the risk of infection SOUTH AFRICA 13 are living with HIV 6 have been treated for TB Source: International Centre for Prison Studies World Prison Briefs http://www.prisonstudies.org/world-prison-brief. 6

Sexual violence, unsafe sexual practices and unsafe drug injection practices Prison populations are predominantly comprised of men aged 19 35 years: a segment of the population that is at higher risk of HIV infection prior to entering prison (9). The actual prevalence of sexual activity is likely to be much higher than that reported, mainly due to denial, fear of stigma and homophobia as well as the criminalization of sex between men. Many prison systems provide condoms, including in countries in western Europe, parts of eastern Europe and central Asia, as well as Australia, Canada, Indonesia, the Islamic Republic of Iran, South Africa and the United States of America. There is evidence that condoms can be provided in a wide range of prison settings including in countries where same-sex activity is criminalized and that prisoners use condoms to prevent HIV infection during sexual activity when condoms are accessible in prisons (20). While much of the sex in prisons is consensual, rape and sexual abuse are used to exercise dominance (9). About 25% of prisoners suffer violence each year, around 4 5% experience sexual violence and 1 2% are raped (19,21). A study in the United States of America showed that 4% of state and federal prisoners reported one or more incidents of sexual victimization (22). Women prisoners are also vulnerable to sexual assault, including rape, by both male staff and other male prisoners (5). 1 They are also susceptible to sexual exploitation and may engage in sex for exchange of goods (5). About 25% of prisoners suffer violence each year, around 4 5% experience sexual violence and 1 2% are raped. People who inject drugs often continue drug use inside prison. Many prisoners initiate injecting drugs for the first time in prison (13). Unsterile injection equipment is often shared in the absence of the provision of needles and syringes. HIV infections among prisoners can be averted by the provision of noncoercive harm reduction programmes. Available evidence indicates that most harm-reduction programmes, including opioid substitution therapy and needle and syringe programmes, can be implemented within prisons without compromising security or increasing illicit drug use (23). 1 There are countries where women prisoners are held in small facilities adjacent to or within prisons for men. In some prison facilities, there are no separate quarters for women and they may be supervised by male prison staff. 7

Inappropriate, ineffective and excessive laws The high incarceration rates that lead to overcrowding largely stem from inappropriate, ineffective and excessive national laws and criminal justice policies. People who are poor, discriminated against and marginalized by society disproportionately populate prisons all over the world (24,25). Inappropriate, ineffective and excessive criminal laws are widespread across countries, and particularly affect people living with HIV and other key populations. Inappropriate, ineffective and excessive criminal laws are widespread across countries and particularly affect people living with HIV and other groups of people who are at higher risk of HIV. Because of weak criminal justice systems, people who are detained may have to wait for long periods during the investigation of a crime, while awaiting trial and before sentencing (26). These delays increase the likelihood of acquiring HIV (26). CLOSING THE GAP Prisoner health, particularly in relation to communicable diseases, is a critical concern. An important step to ensure prisoners access to the health services available without discrimination (18) is to assign responsibility for prison health with the ministry of health in each country (26). Protective laws, policies and programmes that are adequately resourced, monitored and enforced can improve the health and safety of prisoners as well as the community as a whole. A comprehensive package of interventions for HIV prevention, treatment and care in prisons and other closed settings has been put forward by the UNODC (15). 2 This package of 15 interventions has the greatest impact when delivered as a whole and includes: In addition to interventions essential for HIV prevention and treatment, efforts are urgently needed to address broader concerns related to penal reform and overcrowding of prisons. Access to HIV treatment, including preventing mother-to-child transmission and post-exposure prophylaxis. Providing condoms and water-based lubricants in prisons and closed settings, including in countries in which same-sex activity is criminalized. 2 The comprehensive package consists of 15 interventions that are essential for effective HIV prevention and treatment in closed settings. While each of these interventions alone is useful in addressing HIV in prisons, together they form a package and have the greatest impact when delivered as a whole. They are: 1. information, education and communication; 2. HIV testing and counselling; 3. treatment, care and support; 4. prevention, diagnosis and treatment of tuberculosis; 5. prevention of mother-to-child transmission of HIV; 6. condom programmes; 7. prevention and treatment of sexually transmitted infections; 8. prevention of sexual violence; 9. drug dependence treatment; 10. needle and syringe programmes; 11. vaccination, diagnosis and treatment of viral hepatitis; 12. post-exposure prophylaxis; 13. prevention of transmission through medical or dental services; 14. prevention of transmission through tattooing, piercing and other forms of skin penetration; and 15. protecting staff from occupational hazards. 8

Adopting policies and strategies for the prevention, detection and elimination of all forms of violence. Offering harm-reduction programmes, including opioid substitution therapy and needle and syringe programmes. In addition to interventions essential for HIV prevention and treatment, efforts are urgently needed to address broader concerns related to penal reform and overcrowding of prisons. Such measures include: Reforming laws so that they are human rights and evidence-informed to ensure that people who are dependent on drugs, engage in sex work or have same-sex relations are not criminalized. Ensuring that people who are dependent on drugs can access voluntary treatment as an alternative to incarceration, which substantially increases recovery, reduces crime and criminal justice costs and reduces the number of people being incarcerated. Improving access to legal representation for people who have been detained (27) and increasing the availability of non-custodial alternatives, including community service and bail (28). HOW TO CLOSE THE GAP 01 Improve health-care provision, including harm reduction services 02 Reduce prison overcrowding 03 Address unsafe sex and sexual violence 04 Reform inappropriate laws Harm reduction programmes in Spain help keep HIV incidence and AIDS rates low 8 Cases per 1000 inmates 7 6 5 4 3 2 1 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Seroconversion (incidence: cases per 1000 inmates HIV negative) AIDS rate (incidence: cases per 1000 inmates) Source: T. Hernandez-Fernandez, JM Arroyo-Cobo, Results of the Spanish experience: a comprehensive approach to HIV and HCV in prisons, National Plan on AIDS, Health Department, Social and Equality Policy, Rev Esp Sanid Penit 2010. 9

10

UNAIDS / JC2656 (English original, July 2014, updated September 2014) ISBN 978-92-9253-062-4 Copyright 2014. Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. Publications produced by UNAIDS can be obtained from the UNAIDS Information Production Unit. Reproduction of graphs, charts, maps and partial text is granted for educational, not-for-profit and commercial purposes as long as proper credit is granted to UNAIDS: UNAIDS + year. For photos, credit must appear as: UNAIDS/name of photographer + year. Reproduction permission or translation-related requests whether for sale or for non-commercial distribution should be addressed to the Information Production Unit by e-mail at: publicationpermissions@unaids.org. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of UNAIDS concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. UNAIDS does not warrant that the information published in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank and works closely with global and national partners to maximize results for the AIDS response. Learn more at unaids.org and connect with us on Facebook and Twitter. Printed on FSC-certified paper 11

20 Avenue Appia CH-1211 Geneva 27 Switzerland +41 22 791 3666 distribution@unaids.org unaids.org